Medicare Enrolled

Dr. Lihong Wei, M.D.

Optician · Fresh Meadows, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
17660 UNION TPKE, Fresh Meadows, NY 11366
7184602300
In practice since 2006 (19 years)
NPI: 1861574576 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wei from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wei? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wei

Dr. Lihong Wei is an optician specialist in Fresh Meadows, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wei performed 13,816 Medicare services across 1,238 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wei received a total of $13,861 from 34 pharmaceutical and/or device companies across 248 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wei is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 5% volume in NY $13,861 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13,816
Medicare services
Top 5% in NY for optician
1,238
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~727 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 5,580 $18 $56
Epoetin alfa injection (Procrit) for anemia
An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis.
2,200 $6 $37
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
997 $8 $16
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
990 $0 $1
Anti-nausea injection (Aloxi/palonosetron) 970 $1 $68
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
925 $8 $45
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
598 $114 $475
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
416 $78 $383
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
350 $13 $115
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
313 $15 $134
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
124 $1 $12
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
119 $126 $955
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
77 $73 $322
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
65 $60 $391
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
39 $122 $605
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
21 $168 $641
New patient office visit, complex (60-74 min) 18 $208 $919
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
14 $135 $736
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
76.2% medium
22.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,861
Total received (2018-2024)
Avg $1,980/year across 7 years
Top 11% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
248
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,161 (51.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,342 (45.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$358 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$125
2023
$271
2022
$390
2021
$283
2020
$161
2019
$3,292
2018
$9,340

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
IBSA Pharma Inc.
$125
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,420
Puma Biotechnology, Inc.
$1,688
Celgene Corporation
$1,621
Novartis Pharmaceuticals Corporation
$730
Gilead Sciences, Inc.
$606
Exelixis Inc.
$589
AstraZeneca Pharmaceuticals LP
$551
Genentech USA, Inc.
$494
Incyte Corporation
$375
Janssen Biotech, Inc.
$375
PFIZER INC.
$374
Takeda Pharmaceuticals U.S.A., Inc.
$357
Amgen Inc.
$328
Merck Sharp & Dohme Corporation
$276
Neurocrine Biosciences, Inc.
$265
Astellas Pharma US Inc
$248
Lilly USA, LLC
$209
E.R. Squibb & Sons, L.L.C.
$192
TESARO, Inc.
$182
Bayer HealthCare Pharmaceuticals Inc.
$144
IBSA Pharma Inc.
$125
Teva Pharmaceuticals USA, Inc.
$125
BeiGene USA, Inc.
$125
Seattle Genetics, Inc.
$111
GENZYME CORPORATION
$109
Verastem, Inc.
$55
Taiho Oncology, Inc.
$37
Janssen Scientific Affairs, LLC
$29
Pharmacyclics LLC, An AbbVie Company
$22
AbbVie, Inc.
$22
Horizon Pharma plc
$21
Mirati Therapeutics, Inc.
$21
Eisai Inc.
$21
Tactile Systems Technology Inc
$14
Top 3 companies account for 48.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AUSTEDO · Abraxane · Alecensa · Aranesp · Avastin · BOSULIF · BRUKINSA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELITEK · Erleada · FLEXITOUCH · GAZYVA · GILOTRIF · IBRANCE · IMFINZI · INGREZZA · INREBIC · Imbruvica · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · LYNPARZA · Lenvima · Licart · Lonsurf · MEKINIST · NINLARO · Nerlynx · Neulasta · OPDIVO · ORGOVYX · Otezla · PIQRAY · PROMACTA · Pomalyst · Prolia · RYBREVANT · RYDAPT · Revlimid · SUTENT · TAGRISSO · TASIGNA · TECENTRIQ · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Vemlidy · Vitrakvi · XALKORI · XOSPATA · XTANDI · Xofigo · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (52%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Fresh Meadows?
Compare opticians in the Fresh Meadows area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
16,613
Per 100K population
713.0
County median income
$84,961
Nearest hospital
QUEENS HOSPITAL CENTER
1.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wei is a mixed practice specialist, with above-average Medicare volume (top 5% in NY), with low-engagement industry engagement in the top 11% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wei experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Wei performed 5,580 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wei receive payments from pharmaceutical companies?
Yes. Dr. Wei received a total of $13,861 from 34 companies across 248 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wei's costs compare to other opticians in Fresh Meadows?
Dr. Wei's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wei) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →